401 results on '"Maciejewski, J P"'
Search Results
2. Constitutive modeling of cyclic deformation of metals under strain controlled axial extension and cyclic torsion
3. Genomic determinants of chronic myelomonocytic leukemia
4. A Case of Aluminum Nitride Embrittlement of Heavy Wall Cast Steel
5. Deletion of Ptpn1 induces myeloproliferative neoplasm
6. Complete mutational spectrum of the autophagy interactome: a novel class of tumor suppressor genes in myeloid neoplasms
7. Epistasis between TIFAB and miR-146a: neighboring genes in del(5q) myelodysplastic syndrome
8. Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes
9. Molecular predictors of response in patients with myeloid neoplasms treated with lenalidomide
10. Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes
11. GFI1 as a novel prognostic and therapeutic factor for AML/MDS
12. Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia
13. Comprehensive quantitative proteomic profiling of the pharmacodynamic changes induced by MLN4924 in acute myeloid leukemia cells establishes rationale for its combination with azacitidine
14. Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides
15. Defining AML and MDS second cancer risk dynamics after diagnoses of first cancers treated or not with radiation
16. Runx1 repression by histone deacetylation is critical for Setbp1-induced mouse myeloid leukemia development
17. Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms
18. Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM)
19. PRPF8 defects cause missplicing in myeloid malignancies
20. High prevalence and allele burden-independent prognostic importance of p53 mutations in an inner-city MDS/AML cohort
21. Tofacitinib as a novel salvage therapy for refractory T-cell large granular lymphocytic leukemia
22. Recurrent genetic defects on chromosome 7q in myeloid neoplasms
23. Alternatively spliced, truncated GCSF receptor promotes leukemogenic properties and sensitivity to JAK inhibition
24. Spring Fatigue Fractures Due to Microstructural Changes in Service
25. Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms
26. Granulocyte colony-stimulating factor receptor T595I (T618I) mutation confers ligand independence and enhanced signaling
27. Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells
28. Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies
29. Activation of the mTOR signaling pathway by L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts
30. Incident hyperglycemia, parenteral nutrition administration and adverse outcomes in patients with myeloma admitted for initial auto-SCT
31. Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies
32. Naive T-cells in myelodysplastic syndrome display intrinsic human telomerase reverse transcriptase (hTERT) deficiency
33. Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletion
34. Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders
35. CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors
36. A novel view of paroxysmal nocturnal hemoglobinuria pathogenesis: more motile PNH hematopoietic stem/progenitor cells displace normal HSPCs from their niches in bone marrow due to defective adhesion, enhanced migration and mobilization in response to erythrocyte-released sphingosine-1 phosphate gradient
37. Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study
38. SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts
39. CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors
40. p53 Independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia
41. Deletions of Xp22.2 including PIG-A locus lead to paroxysmal nocturnal hemoglobinuria
42. Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies
43. TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p
44. Fracture Assessment of Martempered and Quenched and Tempered Alloy Steel
45. UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutation
46. Regulation of IL-2 expression by transcription factor BACH2 in umbilical cord blood CD4+ T cells
47. Allogeneic transplantation of multiple umbilical cord blood units in adults: role of pretransplant-mixed lymphocyte reaction to predict host-vs-graft rejection
48. Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation
49. Base excision repair dysfunction in a subgroup of patients with myelodysplastic syndrome
50. Epidemiology and risk factors for infections in myelodysplastic syndromes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.